Carolyn Plourde, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 193 Main St, Suite 9, Norway, ME 04268 Phone: 207-743-7605 Fax: 207-743-1579 |
Gregory J Hardy, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 193 Main St, Suite 3, Norway, ME 04268 Phone: 207-743-7605 Fax: 207-743-1579 |
Mark A Klemperer, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 193 Main St, Suite 3, Norway, ME 04268 Phone: 207-743-7605 Fax: 207-743-1579 |
Jordan Faloon, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 193 Main St Ste 3, Norway, ME 04268 Phone: 207-743-7605 |
News Archive
Most existing treatments for pathological bone loss inhibit osteoclasts (bone-destroying cells) to limit bone degradation. However, by doing this, they also prevent bone formation since it is stimulated by the presence of these very same osteoclast cells. Researchers from the CNRS, Inserm and the Université de Montpellier and Université Jean Monnet - Saint-étienne have developed a new approach for preventing the destructive activity of osteoclasts without affecting their viability.
Richards Packaging Income Fund (the "Fund") announced today its cash distribution for the month ended December 31, 2009 of Cdn$0.0655 per unit.
In the future, several illnesses can be quickly and painlessly diagnosed by the optical analysis of isotopes contained in exhaled air. VTT developed its first prototype for this purpose.
Johannesburg Consolidated Investments Limited, a South African-based investment and finance company, was recently ordered to pay $188 million to Hemispherx Biopharma Inc. a biopharmaceutical company, for fraudulently obtaining confidential and proprietary information.
› Verified 8 days ago